Publications by authors named "Mirjam Knol"

Claim this Profile
R
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study.
Esther Kissling, Baltazar Nunes, Mariëtte Hooiveld, Iván Martínez-Baz, Susana Monge, Mirjam Knol

Am J Epidemiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study.
Marit Middeldorp, Jesca G M Brouwer, Janneke W Duijster, Mirjam J Knol, Folkert J van Kemenade

Lancet Reg Health Eur· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating additive interaction in 2-stage individual participant data meta-analysis.
Maartje Basten, Lonneke A van Tuijl, Kuan-Yu Pan, Adriaan W Hoogendoorn, Femke Lamers, Mirjam J Knol

Am J Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The indirect effect of the bivalent human papillomavirus vaccination program: an observational cohort study.
Marit Middeldorp, Janneke W Duijster, Mirjam J Knol, Birgit H B van Benthem, Johannes Berkhof

BMC Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population.
Charlotte Lanièce Delaunay, Baltazar Nunes, Susana Monge, Marit de Lange, Gergő Túri, Mirjam Knol

Int J Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the effect of COVID-19 vaccination and prior infection on cycle threshold values as a proxy of SARS-CoV-2 viral load.
Stijn P Andeweg, Jan van de Kassteele, Xiaorui Wang, Noortje van Maarseveen, Boris Vlaemynck, Mirjam J Knol

Int J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the Netherlands.
Anne J Huiberts, Siméon de Bruijn, Stijn P Andeweg, Christina E Hoeve, Maarten Schipper, Mirjam J Knol

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of bivalent HPV vaccination against invasive cervical cancer and CIN3+ in the Netherlands: a national linkage study.
Marit Middeldorp, Jesca G M Brouwer, Janneke W Duijster, Mirjam J Knol, Folkert J van Kemenade

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for invasive group A streptococcal infection in children aged 6 months to 5 years: a case-control study, the Netherlands, February-May 2023.
Elizabeth I Hazelhorst, Catharina E van Ewijk, Cornelia C H Wielders, Margreet J M Te Wierik, Susan J M Hahné, Mirjam J Knol

Epidemiol Infect· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
Christel E Hoeve, Nienke Neppelenbroek, Eric R A Vos, Anne J Huiberts, Stijn P Andeweg, Mirjam Knol

Epidemiol Infect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity.
Catharina E van Ewijk, Sara Suárez Hernández, Ronald H J Jacobi, Mirjam J Knol, Susan J M Hahné

Vaccine X· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.
Claudia Laarman, Susan J Hahné, Hester E de Melker, Mirjam J Knol

PLoS One· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on neonatal outcomes.
Anne J Huiberts, Ilse J Oosting, Hester E de Melker, Janneke H H M van de Wijgert, Diederick E Grobbee, Mirjam J Knol

Epidemiol Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed consent for national registration of COVID-19 vaccination caused information bias of vaccine effectiveness estimates mostly in older adults: a bias correction study.
Cornelis H van Werkhoven, Brechje de Gier, Scott A McDonald, Hester E de Melker, Susan J M Hahné, Mirjam J Knol

J Clin Epidemiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - the VAccine Study COVID-19 (VASCO).
Anne J Huiberts, Christina E Hoeve, Marjolein N Kooijman, Hester E de Melker, Susan Jm Hahné, Mirjam J Knol

BMJ Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.
Anne J Huiberts, Susan van den Hof, Mirjam J Knol

Int J Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between adverse events after COVID-19 vaccination and anti-SARS-CoV-2 antibody concentrations, the Netherlands, May 2021 to November 2022: a population-based prospective cohort study.
Minke R Holwerda, Christina E Hoeve, Anne J Huiberts, Gerco den Hartog, Hester E de Melker, Mirjam J Knol

Euro Surveill· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections.
Anne Jasmijn Sellies, Mirjam J Knol, Hester E de Melker, Patricia C J L Bruijning-Verhagen, Annemarijn R de Boer

Vaccine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study.
Caren van Roekel, Eero Poukka, Topi Turunen, Hanna Nohynek, Lance Presser, Mirjam J Knol

J Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Anne J Huiberts, Christina E Hoeve, Brechje de Gier, Jeroen Cremer, Bas van der Veer, Mirjam J Knol

Euro Surveill· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studies.
Cheyenne C E van Hagen, Anne J Huiberts, Elizabeth N Mutubuki, Hester E de Melker, Eric R A Vos, Mirjam J Knol

PLoS One· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands.
Pieter T de Boer, Cornelis H van Werkhoven, Albert Jan van Hoek, Mirjam J Knol, Elisabeth A M Sanders

BMC Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023.
C Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E de Melker, Mirjam J Knol

Euro Surveill· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, Mirjam J Knol

Euro Surveill· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, Mirjam J Knol

Euro Surveill· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis